Reports
Sale
Scar Treatment Market Size, Share, Trends, Growth, Analysis: By Scar Type: Atrophic Scars, Hypertrophic and Keloid Scars, Contracture Scars, Stretch Marks; By Product: Topical Products, Laser Products, Injectable, Others; By End User: Hospitals, Ambulatory Surgical Centers, Others; Regional Analysis; Market Dynamics; Supplier Landscape, 2024-2032
Scar Treatment Market Outlook
The scar treatment market size was valued at USD 20.32 billion in 2023, driven by the rising prevalence of demand for cosmetic procedures across the 8 major markets. The market is expected to grow at a CAGR of 11% during the forecast period of 2024-2032, with the values likely to rise from USD 22.50 billion in 2024 to USD 51.39 billion by 2032.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Scar Treatment Market Overview
Scar treatment includes a range of techniques and products used to reduce, mask, or completely remove scars on the skin. Scars may be caused by injuries, surgeries, burns, acne, and other skin disorders. It develops as a result of the body's natural healing process. Topical creams, gels, silicone sheets, laser therapy, surgery, and injections are amongst the common treatments for treating scars.
The scar treatment market growth is driven by individuals becoming more self-conscious about their appearance. This has resulted in increased scar removal and reduction treatments. Consequently, resulting in increased incidence in approvals from regulatory authorities. For instance, in August 2023, FDA approved Sofwave Medical Ltd.'s Precise SUPERB Applicator to treat acne scars, expanding its list of approved uses beyond cellulite. After three sessions, a multicenter clinical research spread across multiple US locations showed a notable improvement in the appearance of acne scars. Most patients expressed relief and great pleasure with their outcomes. There were no significant adverse events in the research, which showed a positive safety profile.
To meet the rising scar treatment market demand, mergers and collaborations are witnessing a significant surge. In June 2023, International Medical Lasers (IML) partnered with DEKA Trio to offer laser accessories, including a scanner for CO2 laser-assisted scar reconstruction. The terms of agreement also focused on an FDA approved novel scanner for surgical scar correction By collaborating with global medical providers and manufacturers, new-age and technology driven companies are bringing cutting-edge medical technology to the markets, further driving its growth.
The scar treatment market share for products and services continues to expand, driven by rising application in the realm of medical aesthetics for non-surgical alternatives. People are looking for less intrusive ways to repair scars and rejuvenate their skin instead of undergoing typical surgical procedures. As laser-based procedures for skin rejuvenation and scar correction become more common, there is an increasing demand for cutting-edge instruments and technology that can produce good outcomes with little risk or downtime.
Scar Treatment Market Trends
| Key Trend | Impact |
| Increased Application of Advanced Technologies | Regarding its precision and effectiveness, technologies such as radiofrequency devices, laser therapy, and microneedling are becoming more and more popular. These techniques provide accurate scar tissue targeting and productive outcomes, thereby, contributing to elevated scar treatment market growth. |
| Preference for Non-Surgical Solutions | The growing inclination towards minimally invasive procedures that have lower risks and downtime has led to an increase in demand for non-surgical scar treatment solutions. These therapies, such as microneedling and laser therapy, are appealing to people looking for non-surgical scar control that works well. They provide more accessibility to a broader spectrum of patients, reduced recovery periods, and fewer side effects. These therapies are made easier by advanced technologies, which also minimize invasiveness while producing effective results. |
| Rising Demand for Cosmetic Procedures | The scar therapy treatment market size is expanding due to rising demand for cosmetic procedures brought on by social and cultural reasons. People are seeking scar treatments to improve their appearance and increase their self-esteem. This tendency is indicative of a larger cultural focus on self-improvement and aesthetics. |
| Customized Treatment Plans | Healthcare professionals are adopting customized scar treatment regimens that consider requirements of each patient and take several elements including skin type, location, size, and scar type into account. This tailored method guarantees that treatment plans are formulated to maximize efficacy and patient satisfaction, indicating a change in scar management toward more patient-centred care. |
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Scar Treatment Market Segmentation
Market Breakup by Scar Type
- Atrophic Scars
- Hypertrophic and Keloid Scars
- Contracture Scars
- Stretch Marks
The market segmentation by treatment type includes atrophic scars, hypertrophic and keloid scars, contracture scars, and stretch marks. This market segment illustrates the different types of treatment types.
Market Breakup by Product
- Topical Products
- Creams
- Gels
- Silicon Sheets
- Others
- Laser Products
- CO2 Laser
- Pulse-dyed Laser
- Others
- Injectable
- Others
Based on products, the scar treatment market is segmented into topical products, laser products, injectables, and others. Topical products include creams, gels, silicone sheets, and other formulations. Laser products comprise CO2 lasers, pulse-dyed lasers, and other laser devices. Injectable treatments are also offered for scar management. These segments reflect the diverse range of scar treatment options available, catering to varying patient needs and preferences. From non-invasive topical solutions to advanced laser therapies and injectable treatments, the market offers a comprehensive array of products aimed at reducing the appearance of scars and improving skin texture, ensuring a tailored approach to scar management.
Market Breakup by End User
- Hospitals
- Ambulatory Surgical Centers
- Others
End-users of scar treatment include hospitals, and ambulatory surgical centers, among others. These healthcare facilities provide access to treatment to diverse patient populations and clinical needs.
Market Breakup by Region
- United States
- EU-4 and the United Kingdom
- Germany
- France
- Italy
- Spain
- United Kingdom
- Japan
- India
Based on regions, the market is divided into United States, EU-4 (Germany, France, Italy, and Spain) and the United Kingdom, along with Japan, and India. These areas reflect diverse healthcare environments and consumer preferences across various geographic areas. United States with a robust healthcare infrastructure is expected to lead the market share in the forecast period, while India and Japan are likely to witness expedited market growth.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Scar Treatment Market: Competitor Landscape
The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
- Alliance Pharma PLC
- Perrigo Company plc
- Newmedical Technology Inc.
- Sonoma Pharmaceuticals, Inc.
- HRA Pharma
- Boston Scientific Corporation
- CCA Industries, Inc.
- Avita Medical,Inc.
- Smith & Nephew PLC
- Shanghai Fosun Pharmaceutical（Group）Co., Ltd.
- Sientra, Inc.
- Mölnlycke Health Care AB
- Merz Pharma
- POLYTECH Health & Aesthetics GmbH
- CYNOSURE LUTRONIC
Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.
Key Highlights of the Report
| REPORT FEATURES | DETAILS |
| Base Year | 2023 |
| Historical Period | 2017-2023 |
| Forecast Period | 2024-2032 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Scar Type |
|
| Breakup by Product |
|
| Breakup by End User |
|
| Breakup by Region |
|
| Market Dynamics |
|
| Supplier Landscape |
|
| Companies Covered |
|
Key Queries Solved in the Scar Treatment Market Report
- How is the market landscape expected to evolve in the forecast period?
- What future trends can be anticipated in the market?
- What will be the effect of each driver, challenge, and opportunity on the market?
- Which regional market is expected to experience expedited growth during the forecast period?
- Which production type will lead the market growth?
- Which end user is expected to dominate the respective market segment?
- What are the key research initiatives expected to boost the market value during the forecast period?
- Which treatment type is poised to make the highest impact on the Scar treatment market growth?
- What are the market shares, strategies, and product portfolios of the leading players in the market?
- How is the regulatory landscape shaping the market?
- What are the market dynamics, trends, and growth prospects in the key regional markets?
- How is technology innovation impacting the development of scar treatment?
- What are the investment opportunities and potential risks associated with the market?
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.
1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage – Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Scar Treatment Market Overview – 8 Major Markets
3.1 Scar Treatment Market Historical Value (2017-2023)
3.2 Scar Treatment Market Forecast Value (2024-2032)
4 Scar Overview
4.1 Guidelines and Stages
4.2 Pathophysiology
4.3 Screening and Diagnosis
4.4 Scar Pathway
5 Patient Profile
5.1 Patient Profile Overview
5.2 Patient Psychology and Emotional Impact Factors
5.3 Risk Assessment and Scar Type Success Rate
6 Scar Epidemiology Scenario and Forecast – 8 Major Markets
6.1 8MM Epidemiology Scenario Overview (2017-2032)
6.2 United States Scar Epidemiology Scenario and Forecast (2017-2032)
6.3 EU-4 and United Kingdom Scar Epidemiology Scenario and Forecast (2017-2032)
6.3.1 Germany Scar Epidemiology Scenario and Forecast (2017-2032)
6.3.2 France Scar Epidemiology Scenario and Forecast (2017-2032)
6.3.3 Italy Scar Epidemiology Scenario and Forecast (2017-2032)
6.3.4 Spain Scar Epidemiology Scenario and Forecast (2017-2032)
6.3.5 United Kingdom Scar Epidemiology Scenario and Forecast (2017-2032)
6.4 Japan Scar Epidemiology Scenario and Forecast (2017-2032)
6.5 India Scar Epidemiology Scenario and Forecast (2017-2032)
7 Scar Treatment Market Landscape – 8 Major Markets
7.1 Scar Treatment: Developers Landscape
7.1.1 Analysis by Year of Establishment
7.1.2 Analysis by Company Size
7.1.3 Analysis by Region
7.2 Scar Treatment: Product Landscape
7.2.1 Analysis by Scar Type
7.2.2 Analysis by Product Type
7.2.3 Analysis by End User
8 Scar Challenges and Unmet Needs
8.1 Scar Type Pathway Challenges
8.2 Compliance and Drop-Out Analysis
8.3 Awareness and Prevention Gaps
9 Cost of Scar Treatment
10 Scar Treatment Market Dynamics
10.1 Market Drivers and Constraints
10.2 SWOT Analysis
10.3 Porter’s Five Forces Model
10.4 Key Demand Indicators
10.5 Key Price Indicators
10.6 Industry Events, Initiatives, and Trends
10.7 Value Chain Analysis
11 Scar Treatment Market Segmentation (2017-2032) - 8 Major Markets
11.1 Scar Treatment Market (2017-2032) by Scar Type
11.1.1 Market Overview
11.1.2 Atrophic Scars
11.1.3 Hypertrophic and Keloid Scars
11.1.4 Contracture Scars
11.1.5 Stretch Marks
11.2 Scar Treatment Market (2017-2032) by Product
11.2.1 Market Overview
11.2.2 Topical Products
11.2.2.1 Creams
11.2.2.2 Gels
11.2.2.3 Silicon Sheets
11.2.2.4 Others
11.2.3 Laser Products
11.2.3.1 CO2 Laser
11.2.3.2 Pulse-dyed Laser
11.2.3.3 Others
11.2.4 Injectable
11.2.5 Others
11.3 Scar Treatment Market (2017-2032) by End User
11.3.1 Hospitals
11.3.2 Ambulatory Surgical Centers
11.3.3 Others
11.4 Scar Treatment Market (2017-2032) by Region
11.4.1 Market Overview
11.4.2 United States
11.4.3 EU-4 and the United Kingdom
11.4.3.1 Germany
11.4.3.2 France
11.4.3.3 Italy
11.4.3.4 Spain
11.4.3.5 United Kingdom
11.4.4 Japan
11.4.5 India
12 United States Scar Treatment Market (2017-2032)
12.1 United States Scar Treatment Market Historical Value (2017-2023)
12.2 United States Scar Treatment Market Forecast Value (2024-2032)
12.3 United States Scar Treatment Market (2017-2032) by Scar Type
12.3.1 Market Overview
12.3.2 Atrophic Scars
12.3.3 Hypertrophic and Keloid Scars
12.3.4 Contracture Scars
12.3.5 Stretch Marks
12.4 United States Scar Treatment Market (2017-2032) by Product
12.4.1 Market Overview
12.4.2 Topical Products
12.4.2.1 Creams
12.4.2.2 Gels
12.4.2.3 Silicon Sheets
12.4.2.4 Others
12.4.3 Laser Products
12.4.3.1 CO2 Laser
12.4.3.2 Pulse-dyed Laser
12.4.3.3 Others
12.4.4 Injectable
12.4.5 Others
13 EU-4 and United Kingdom Scar Treatment Market (2017-2032)
13.1 EU-4 and United Kingdom Scar Treatment Market Historical Value (2017-2023)
13.2 EU-4 and United Kingdom Scar Treatment Market Forecast Value (2024-2032)
13.3 EU-4 and United Kingdom Scar Treatment Market (2017-2032) by Scar Type
13.3.1 Market Overview
13.3.2 Atrophic Scars
13.3.3 Hypertrophic and Keloid Scars
13.3.4 Contracture Scars
13.3.5 Stretch Marks
13.4 EU-4 and United Kingdom Scar Treatment Market (2017-2032) by Product
13.4.1 Market Overview
13.4.2 Topical Products
13.4.2.1 Creams
13.4.2.2 Gels
13.4.2.3 Silicon Sheets
13.4.2.4 Others
13.4.3 Laser Products
13.4.3.1 CO2 Laser
13.4.3.2 Pulse-dyed Laser
13.4.3.3 Others
13.4.4 Injectable
13.4.5 Others
14 Japan Scar Treatment Market
14.1 Japan Scar Treatment Market Historical Value (2017-2023)
14.2 Japan Scar Treatment Market Forecast Value (2024-2032)
14.3 Japan Scar Treatment Market (2017-2032) by Scar Type
14.3.1 Market Overview
14.3.2 Atrophic Scars
14.3.3 Hypertrophic and Keloid Scars
14.3.4 Contracture Scars
14.3.5 Stretch Marks
14.4 Japan Scar Treatment Market (2017-2032) by Product
14.4.1 Market Overview
14.4.2 Topical Products
14.4.2.1 Creams
14.4.2.2 Gels
14.4.2.3 Silicon Sheets
14.4.2.4 Others
14.4.3 Laser Products
14.4.3.1 CO2 Laser
14.4.3.2 Pulse-dyed Laser
14.4.3.3 Others
14.4.4 Injectable
14.4.5 Others
15 India Scar Treatment Market
15.1 India Scar Treatment Market (2017-2032) Historical Value (2017-2023)
15.2 India Scar Treatment Market (2017-2032) Forecast Value (2024-2032)
15.3 India Scar Treatment Market (2017-2032) by Scar Type
15.3.1 Market Overview
15.3.2 Atrophic Scars
15.3.3 Hypertrophic and Keloid Scars
15.3.4 Contracture Scars
15.3.5 Stretch Marks
15.4 India Scar Treatment Market (2017-2032) by Product
15.4.1 Market Overview
15.4.2 Topical Products
15.4.2.1 Creams
15.4.2.2 Gels
15.4.2.3 Silicon Sheets
15.4.2.4 Others
15.4.3 Laser Products
15.4.3.1 CO2 Laser
15.4.3.2 Pulse-dyed Laser
15.4.3.3 Others
15.4.4 Injectable
15.4.5 Others
16 Regulatory Framework
16.1 Regulatory Overview
16.1.1 US FDA
16.1.2 EU EMA
16.1.3 Japan PMDA
16.1.4 India CDSCO
16.1.5 Others
17 Patent Analysis
17.1 Analysis by Drug Type of Patent
17.2 Analysis by Publication Year
17.3 Analysis by Issuing Authority
17.4 Analysis by Patent Age
17.5 Analysis by CPC Analysis
17.6 Analysis by Patent Valuation
17.7 Analysis by Key Players
18 Grants Analysis
18.1 Analysis by Year
18.2 Analysis by Amount Awarded
18.3 Analysis by Issuing Authority
18.4 Analysis by Grant Application
18.5 Analysis by Funding Institute
18.6 Analysis by NIH Departments
18.7 Analysis by Recipient Organization
19 Clinical Trials Analysis
19.1 Analysis by Trial Registration Year
19.2 Analysis by Trial Status
19.3 Analysis by Trial Phase
19.4 Analysis by Therapeutic Area
19.5 Analysis by Geography
20 Funding and Investment Analysis
20.1 Analysis by Funding Instances
20.2 Analysis by Drug Type of Funding
20.3 Analysis by Funding Amount
20.4 Analysis by Leading Players
20.5 Analysis by Leading Investors
20.6 Analysis by Geography
21 Partnership and Collaborations Analysis
21.1 Analysis by Partnership Instances
21.2 Analysis by Drug Type of Partnership
21.3 Analysis by Leading Players
21.4 Analysis by Geography
22 Supplier Landscape
22.1 Alliance Pharma PLC
22.1.1 Financial Analysis
22.1.2 Product Portfolio
22.1.3 Demographic Reach and Achievements
22.1.4 Mergers and Acquisitions
22.1.5 Certifications
22.2 Perrigo Company plc
22.2.1 Financial Analysis
22.2.2 Product Portfolio
22.2.3 Demographic Reach and Achievements
22.2.4 Mergers and Acquisitions
22.2.5 Certifications
22.3 Newmedical Technology Inc.
22.3.1 Financial Analysis
22.3.2 Product Portfolio
22.3.3 Demographic Reach and Achievements
22.3.4 Mergers and Acquisitions
22.3.5 Certifications
22.4 Sonoma Pharmaceuticals, Inc.
22.4.1 Financial Analysis
22.4.2 Product Portfolio
22.4.3 Demographic Reach and Achievements
22.4.4 Mergers and Acquisitions
22.4.5 Certifications
22.5 HRA Pharma
22.5.1 Financial Analysis
22.5.2 Product Portfolio
22.5.3 Demographic Reach and Achievements
22.5.4 Mergers and Acquisitions
22.5.5 Certifications
22.6 Boston Scientific Corporation
22.6.1 Financial Analysis
22.6.2 Product Portfolio
22.6.3 Demographic Reach and Achievements
22.6.4 Mergers and Acquisitions
22.6.5 Certifications
22.7 CCA Industries, Inc.
22.7.1 Financial Analysis
22.7.2 Product Portfolio
22.7.3 Demographic Reach and Achievements
22.7.4 Mergers and Acquisitions
22.7.5 Certifications
22.8 Avita Medical,Inc.
22.8.1 Financial Analysis
22.8.2 Product Portfolio
22.8.3 Demographic Reach and Achievements
22.8.4 Mergers and Acquisitions
22.8.5 Certifications
22.9 Smith & Nephew PLC
22.9.1 Financial Analysis
22.9.2 Product Portfolio
22.9.3 Demographic Reach and Achievements
22.9.4 Mergers and Acquisitions
22.9.5 Certifications
22.10 Shanghai Fosun Pharmaceutical（Group）Co., Ltd.
22.10.1 Financial Analysis
22.10.2 Product Portfolio
22.10.3 Demographic Reach and Achievements
22.10.4 Mergers and Acquisitions
22.10.5 Certifications
22.11 Sientra, Inc.
22.11.1 Financial Analysis
22.11.2 Product Portfolio
22.11.3 Demographic Reach and Achievements
22.11.4 Mergers and Acquisitions
22.11.5 Certifications
22.12 Mölnlycke Health Care AB
22.12.1 Financial Analysis
22.12.2 Product Portfolio
22.12.3 Demographic Reach and Achievements
22.12.4 Mergers and Acquisitions
22.12.5 Certifications
22.13 Merz Pharma
22.13.1 Financial Analysis
22.13.2 Product Portfolio
22.13.3 Demographic Reach and Achievements
22.13.4 Mergers and Acquisitions
22.13.5 Certifications
22.14 POLYTECH Health & Aesthetics GmbH
22.14.1 Financial Analysis
22.14.2 Product Portfolio
22.14.3 Demographic Reach and Achievements
22.14.4 Mergers and Acquisitions
22.14.5 Certifications
22.15 CYNOSURE LUTRONIC
22.15.1 Financial Analysis
22.15.2 Product Portfolio
22.15.3 Demographic Reach and Achievements
22.15.4 Mergers and Acquisitions
22.15.5 Certifications
23 Scar Treatment Market - Distribution Model (Additional Insight)
23.1 Overview
23.2 Potential Distributors
23.3 Key Parameters for Distribution Partner Assessment
24 Key Opinion Leaders (KOL) Insights (Additional Insight)
25 Company Competitiveness Analysis (Additional Insight)
25.1 Very Small Companies
25.2 Small Companies
25.3 Mid-Sized Companies
25.4 Large Companies
25.5 Very Large Companies
26 Payment Methods (Additional Insight)
26.1 Government Funded
26.2 Private Insurance
26.3 Out-of-Pocket
*Additional insights provided are customisable as per client requirements.
* The coverage of the Market Landscape section depends on the data availability and may cover a minimum of 80% of the total market. The EMR team strives to make this section as comprehensive as possible.
Key Questions Answered in the Report
The market attained a value of about USD 20.32 billion in 2023 driven by the rising prevalence of demand for cosmetic procedures across the 8 major markets.
The market is anticipated to grow at a CAGR of 11% during the forecast period of 2024-2032, likely to reach a market value of USD 51.39 billion by 2032.
Growing demands for personalized treatment plans as well as rising disposable incomes are fuelling the demand for the market.
The growing preference for non-surgical scar treatment options is one significant market trends. Methods that reduce scars precisely and effectively, such microneedling and laser therapy, are gaining wide popularity amongst the consumers.
It includes atrophic scars, hypertrophic and keloid scars, contracture scars and stretch marks.
Based on product type, the market for scar treatment includes topical products, laser products, and injectables among others. Topical products include silicone sheets, gels, lotions, and other compositions.CO2 lasers, pulse-dyed lasers, and other laser devices are typical laser products.
End-users of scar treatment include hospitals, and ambulatory surgical centers, among others.
The major regions of the market include the United States, EU-4 (Germany, France, Italy, and Spain), the United Kingdom, Japan, and India.
Key players involved in the market are Alliance Pharma PLC, Perrigo Company plc, Newmedical Technology Inc., Sonoma Pharmaceuticals, Inc., HRA Pharma, Boston Scientific Corporation, CCA Industries, Inc., Avita Medical, Inc., Smith & Nephew PLC, Shanghai Fosun Pharmaceutical (Group) Co., Ltd., Sientra, Inc., Molnlycke Health Care AB, Merz Pharma, POLYTECH Health & Aesthetics GmbH and CYNOSURE LUTRONIC
Purchase Options 10% off
Call us
Purchase Full Report
Mini Report
$ 3299
$2999
-
Selected Sections, One User
-
Printing Not Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Single User License
$ 6599
$5999
-
All Sections, One User
-
One Print Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Five User License
$ 8799
$7999
-
All Sections, Five Users
-
Five Prints Allowed
-
Email Delivery in PDF
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Corporate License
$ 9899
$8999
-
All Sections, Unlimited Users
-
Unlimited Prints Allowed
-
Email Delivery in PDF + Excel
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Any Question? Speak With An Analyst
View A Sample
Did You Miss Anything, Ask Now
Why Expert Market Research?
Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.
NEWSLETTER